Advances in the Management of R/R cHL

 

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)
Avatar

SOHO 2021: Integrating Novel Agents Into the Treatment of Classic HL

By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Ann LaCasce
By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Ann LaCasce
65 views
October 1, 2021
0 Comments
Login to view comments. Click here to Login
Advances in the Management of R/R cHL
16:08
John Kuruvilla

KEYNOTE-204 in R/R cHL: How Does This Trial Influence Our Practice?

07:23
ASH 2021 Conference Coverage on VuMedi

ASH 2021 Five-Year Follow-Up of Keynote-087: Pembrolizumab Monothera…

Feat. A. Herrera
17:03
Stephen M. Ansell

PD-1 Blockade in Hodgkin Lymphoma: Moving Up the Ranks

16:04
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021: Integrating Novel Agents Into the Treatment of Classic HL

Feat. A. LaCasce
08:50
UNC Lineberger Comprehensive Cancer Center

Latest Advances in the Management of R/R cHL: The Era of Novel Thera…

Feat. N. Grover
23:57
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2022

Advanced Stage Hodgkin Lymphoma in 2022: Common Management Issues

Feat. C. Moskowitz
41:23
University of Colorado Division of Hematology

UC Denver ASH Review: Updates on Lymphomas

Feat. S. Bair
17:09
Penn Medicine Abramson Cancer Center

Therapeutic Advances in Hodgkin Lymphoma

Feat. J. Svoboda
29:12
Penn Medicine Abramson Cancer Center

Equitable Access to Hematologic Malignancies Research for Everyone

Feat. C. Guerra
54:37
19th Annual International Ultmann Chicago Lymphoma Symposium

Toxicities Associated With Chronic Therapies for Lymphoma: Case Stud…

Feat. N. Soriano, K. Thorp